Embecta (EMBC) Free Cash Flow Growth (3y) (2023 - 2026)
Embecta (EMBC) Free Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.01 Bn | 120.80 Bn | 1.96 Bn | 30.99% |
| 2 | Becton Dickinson | 44.76 Bn | 43.95 Bn | 2.15 Bn | 414.89% |
| 3 | Alcon | 33.14 Bn | 31.48 Bn | 1.53 Bn | 43.37% |
| 4 | Medline | 33.00 Bn | 30.76 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.47 Bn | 27.81 Bn | 890.98 Mn | 27.06% |
| 6 | West Pharmaceutical Services | 23.76 Bn | 23.32 Bn | 329.20 Mn | -4.85% |
| 7 | Solventum | 14.02 Bn | 13.46 Bn | 1.10 Bn | -37.77% |
| 8 | Cooper Companies | 13.89 Bn | 13.75 Bn | 735.40 Mn | 23.97% |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn | -3.97% |
| 10 | Embecta | 203.40 Mn | 10.00 Mn | 127.80 Mn | 53.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.65% |
| Dec 31, 2025 | -33.20% |
| Sep 30, 2025 | 15.79% |
| Jun 30, 2025 | 43.23% |
| Mar 31, 2025 | -43.65% |
| Dec 31, 2024 | -27.04% |
| Sep 30, 2024 | -28.48% |
| Jun 30, 2024 | -27.99% |
| Mar 31, 2024 | -43.27% |
| Dec 31, 2023 | -28.94% |